|
1
|
Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor.
|
Clin Pharmacokinet
|
2000
|
1.76
|
|
2
|
High-risk prescribing and incidence of frailty among older community-dwelling men.
|
Clin Pharmacol Ther
|
2012
|
1.43
|
|
3
|
Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects.
|
Br J Pharmacol
|
2008
|
1.27
|
|
4
|
Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin.
|
Br J Clin Pharmacol
|
1994
|
1.24
|
|
5
|
Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype.
|
Clin Pharmacol Ther
|
2007
|
1.18
|
|
6
|
Physiologically based pharmacokinetic modeling at the extremes of age.
|
Clin Pharmacol Ther
|
2012
|
1.07
|
|
7
|
Pharmacokinetics of ciprofloxacin in the human eye: a clinical study and population pharmacokinetic analysis.
|
Antimicrob Agents Chemother
|
2000
|
1.03
|
|
8
|
Factors affecting variability in distribution of tacrolimus in liver transplant recipients.
|
Br J Clin Pharmacol
|
2004
|
1.00
|
|
9
|
Population pharmacokinetics of amphotericin B in children with malignant diseases.
|
Br J Clin Pharmacol
|
2001
|
0.97
|
|
10
|
Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects.
|
Br J Clin Pharmacol
|
1996
|
0.91
|
|
11
|
Herb-drug interactions: an evidence based approach.
|
Curr Med Chem
|
2004
|
0.90
|
|
12
|
Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide.
|
Br J Pharmacol
|
2008
|
0.89
|
|
13
|
Validation of methods to study the distribution and protein binding of tacrolimus in human blood.
|
J Pharmacol Toxicol Methods
|
2002
|
0.87
|
|
14
|
Investigating polypharmacy and drug burden index in hospitalised older people.
|
Intern Med J
|
2013
|
0.85
|
|
15
|
Amphotericin B in children with malignant disease: a comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion.
|
Antimicrob Agents Chemother
|
1999
|
0.85
|
|
16
|
Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.
|
Clin Pharmacokinet
|
1999
|
0.85
|
|
17
|
Tissue distribution of terbinafine in rats.
|
J Pharm Sci
|
2001
|
0.84
|
|
18
|
Assessment of in vitro and in vivo recovery of gallamine using microdialysis.
|
J Pharmacol Toxicol Methods
|
2001
|
0.84
|
|
19
|
Pharmacokinetics and pharmacodynamics of hydroxychloroquine enantiomers in patients with rheumatoid arthritis receiving multiple doses of racemate.
|
Chirality
|
1994
|
0.84
|
|
20
|
HPLC-fluorescence assay for acyclovir in children.
|
Biomed Chromatogr
|
2008
|
0.81
|
|
21
|
Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol.
|
Br J Clin Pharmacol
|
2001
|
0.80
|
|
22
|
Population pharmacokinetics of acyclovir in children and young people with malignancy after administration of intravenous acyclovir or oral valacyclovir.
|
Antimicrob Agents Chemother
|
2009
|
0.80
|
|
23
|
Pharmacokinetics and tissue distribution of cisplatin and conjugates of cisplatin with carboxymethyldextran and A5B7 monoclonal antibody in CD1 mice.
|
J Pharm Sci
|
1997
|
0.80
|
|
24
|
Warfarin metabolites: stereochemical aspects of protein binding and displacement by phenylbutazone.
|
Chirality
|
1993
|
0.79
|
|
25
|
Effect of simvastatin on cyclosporine unbound fraction and apparent blood clearance in heart transplant recipients.
|
Br J Clin Pharmacol
|
1997
|
0.78
|
|
26
|
Determination of terbinafine in tissues.
|
Biomed Chromatogr
|
2000
|
0.78
|
|
27
|
HPLC-UV assay for monitoring total and unbound mycophenolic acid concentrations in children.
|
Biomed Chromatogr
|
2009
|
0.78
|
|
28
|
Influence of environmental and genetic factors on CYP1A2 activity in individuals of South Asian and European ancestry.
|
Clin Pharmacol Ther
|
2012
|
0.78
|
|
29
|
Membrane permeability and lipophilicity in the isolated perfused rat liver: 5-ethyl barbituric acid and other compounds.
|
J Pharmacol Exp Ther
|
1995
|
0.78
|
|
30
|
Fruit juices as perpetrators of drug interactions: the role of organic anion-transporting polypeptides.
|
Clin Pharmacol Ther
|
2012
|
0.78
|
|
31
|
Distribution kinetics of salicylic acid in the isolated perfused rat liver assessed using moment analysis and the two-compartment axial dispersion model.
|
Pharm Res
|
1994
|
0.78
|
|
32
|
Pharmacokinetics of cyclosporine in heart transplant recipients receiving metabolic inhibitors.
|
J Heart Lung Transplant
|
2001
|
0.77
|
|
33
|
Pharmacokinetics of chloramphenicol following administration of intravenous and subcutaneous chloramphenicol sodium succinate, and subcutaneous chloramphenicol, to koalas (Phascolarctos cinereus).
|
J Vet Pharmacol Ther
|
2012
|
0.77
|
|
34
|
Enantioselective disposition of hydroxychloroquine.
|
Br J Clin Pharmacol
|
1996
|
0.75
|
|
35
|
Concentration-effect studies--making sense of sparse concentration data?
|
J Rheumatol
|
1996
|
0.75
|
|
36
|
Knowledge and attitudes regarding the personally controlled electronic health record: an Australian national survey.
|
Intern Med J
|
2014
|
0.75
|
|
37
|
Abdominal functional electrical stimulation to improve respiratory function after spinal cord injury: a systematic review and meta-analysis.
|
Spinal Cord
|
2016
|
0.75
|
|
38
|
Pharmacokinetics of estradiol, progesterone, testosterone and dehydroepiandrosterone after transbuccal administration to postmenopausal women.
|
Climacteric
|
2003
|
0.75
|
|
39
|
[Properties and features of nabumetone].
|
Drugs
|
2000
|
0.75
|
|
40
|
Effect of clofibrate on the chiral disposition of ibuprofen in rats.
|
J Pharmacol Exp Ther
|
1998
|
0.75
|
|
41
|
Application of a high-performance liquid chromatographic assay for the neuromuscular blocker gallamine to analysis of rat plasma, muscle and microdialysate samples.
|
J Chromatogr B Biomed Sci Appl
|
2001
|
0.75
|
|
42
|
Abdominal functional electrical stimulation to improve respiratory function after spinal cord injury: a systematic review and meta-analysis.
|
Spinal Cord
|
2017
|
0.75
|